morpholinoanthracycline mx2 has been researched along with aclarubicin in 1 studies
| Studies (morpholinoanthracycline mx2) | Trials (morpholinoanthracycline mx2) | Recent Studies (post-2010) (morpholinoanthracycline mx2) | Studies (aclarubicin) | Trials (aclarubicin) | Recent Studies (post-2010) (aclarubicin) |
|---|---|---|---|---|---|
| 53 | 15 | 0 | 826 | 97 | 105 |
| Protein | Taxonomy | morpholinoanthracycline mx2 (IC50) | aclarubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 9.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lampidis, TJ; Nguyen-Ba, G; Tapiero, H | 1 |
1 other study(ies) available for morpholinoanthracycline mx2 and aclarubicin
| Article | Year |
|---|---|
Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Topics: Aclarubicin; Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; In Vitro Techniques; Mice; Tumor Cells, Cultured; Verapamil | 1994 |